✦ LIBER ✦

Peripheral Neuropathy Due to Biweekly Paclitaxel, Epirubicin and Cisplatin in Patients with Advanced Ovarian Cancer

✍ Scribed by T.J. Postma; K. Hoekman; J.M.G.H. van Riel; J.J. Heimans; J.B. Vermorken

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peripheral neuropathy due to therapy wit

✍ C.C.P. Verstappen; T.J. Postma; K. Hoekman; J.J. Heimans 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 57 KB

Cisplatin, epirubicin and paclitaxel com

✍ C. Papadimitriou; D. Lazaris; A. Rodolakis; C. Kiamouris; G.M. Gourgoulis; E. Ga 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Paclitaxel, cisplatin and epirubicin (PC

✍ C. Papadimitriou; A. Anagnostopoulos; Z. Voulgaris; G. Vlahos; E. Kioses; T. Akr 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Patient-reported peripheral neuropathy o

✍ David Cella; Helen Huang; Howard D. Homesley; Anthony Montag; Ritu Salani; Koen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 260 KB

Prospective assessment of chemotherapy-i

✍ Katsumasa Kuroi; Kojiro Shimozuma; Yasuo Ohashi; Kazufumi Hisamatsu; Norikazu Ma 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 400 KB

PCN37 PRELIMINARY COST-CONSEQUENCE ANALY

✍ AM Horgan; J Knox; G Liu; PA Bradbury; C Sahi; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB